Category
Core Topics
-
Webinar: A White House Q&A on Monkeypox
The number of new monkeypox cases has declined since this summer, but many questions remain about symptoms, transmission, vaccines, treatments…
-
New legislation may improve advance care planning
Journalists may want to keep an eye on new companion bills recently introduced in the House and Senate. The legislation…
-
Reporting on disparities in HIV testing, PrEP
HIV trends don’t make headlines the way they used to. But we may see an influx of them in the…
-
Resources for covering the ACA preventive care ruling in Texas
Among the many significant parts of the Affordable Care Act, one of the most important for consumers is the requirement…
-
How a news investigation shed light on potential patient privacy violations
There have been continuing repercussions from an investigative story published in June by nonprofit news organization The Markup, in partnership with STAT, describing…
-
How I did it: Reporting on apparent misconduct in influential Alzheimer’s research
Alzheimer’s disease afflicts more than 6 million Americans. Yet since 1906, when Alois Alzheimer first saw characteristic sticky plaques in…
-
How is the U.S. preparing for the “second punch” of antibiotic resistance?
Journalists should check in on how the U.S. government and the nation’s hospitals and medical practices intend to regain ground…
-
A hallucinogen combined with psychotherapy may curb alcohol use disorder
Journalists covering alcoholism may already know that it is the third leading cause of death in the United States, behind tobacco smoking,…
-
Evaluating concerns about accelerated FDA drug approvals
Congress has a chance in September to try to speed the pace of studies needed to confirm whether drugs sold…
-
Will the FDA get more tools for handling accelerated drug approvals?
September is a great time for journalists to examine how well U.S. regulators are handling the accelerated approval pathway for…